Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization-Reference-Cited by-同舟云学术

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

Published:2011-04 Issue:4 Volume:178 Page:1453-1460
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Romero Atocha,Martín Miguel,Cheang Maggie C.U.,López García-Asenjo José Antonio,Oliva Belén,He Xiaping,de la Hoya Miguel,García Sáenz Jose Ángel,Arroyo Fernández Manuel,Díaz Rubio Eduardo,Perou Charles M.,Llopis Trinidad Caldés

Funder

Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation

Fondo Europeo de Desarrollo Regional

NCI Breast SPORE program

Terry Fox Foundation postdoctoral research fellowship

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference47 articles.

1. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients;Ryberg;J Natl Cancer Inst,2008

3. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II;Tewey;Science,1984